热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Brilliant Violet 421™ anti-mouse F4/80 Antib
产品名称：
Brilliant Violet 421™ anti-mouse F4/80 Antib
产品类别：
抗体
产品编号：
123131
产品应用：
123131
[价格]
规格 价格 库存
125µL ￥ 2448 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421? under optimal conditions.
Concentration
?g sizes: 0.2 mg/mL
?L sizes: lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC-F - Verified

SB - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining using the ?g size, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. For immunofluorescent staining using ?l sizes, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood. For immunohistochemical staining on frozen tissue sections, the suggested use of this reagent is 2.0 ?g/ml. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 421? excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421? is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Additional Product Notes

Iterative Bleaching Extended multi-pleXity (IBEX) is a fluorescent imaging technique capable of highly-multiplexed spatial analysis. The method relies on cyclical bleaching of panels of fluorescent antibodies in order to image and analyze many markers over multiple cycles of staining, imaging, and, bleaching. It is a community-developed open-access method developed by the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).

Application References

(PubMed link indicates BioLegend citation)
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  13. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  2. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  3. Hu K, et al. 2022. J Extracell Vesicles. 11:e12199. PubMed
  4. Zahr A, et al. 2016. Nat Commun. 7:10363. PubMed
  5. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  6. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  7. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  8. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  9. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  10. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  11. Jaiswal AK, et al. 2020. Immunobiology. 225:151956. PubMed
  12. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  13. Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed
  14. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  15. Feng J, et al. 2021. iScience. 24:103004. PubMed
  16. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  17. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  18. Li J, et al. 2021. Front Immunol. 12:649285. PubMed
  19. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  20. Iturri L, et al. 2021. Immunity. . PubMed
  21. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  22. Sakai M, et al. 2020. Immunity. 51(4):655-670. PubMed
  23. Nakamoto N, et al. 2019. Nat Microbiol. 4:492. PubMed
  24. Laumonnier Y, et al. 2020. Curr Protoc Immunol. 130:e100. PubMed
  25. Gómez-Díaz C, et al. 2021. iScience. 24:103241. PubMed
  26. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  27. Sun K, et al. 2016. J Exp Med. 213: 1851 - 1864. PubMed
  28. Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed
  29. Zhang X, et al. 2022. Pharmaceutics. 14:. PubMed
  30. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  31. Croasdell A, et al. 2016. J Immunol. 196: 2742 - 2752. PubMed
  32. Karsten C, et al. 2015. J Immunol. 194:1841. PubMed
  33. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  34. Palathingal Bava E, et al. 2022. JCI Insight. 7:. PubMed
  35. Tu J, et al. 2022. Theranostics. 12:747. PubMed
  36. Du W, et al. 2021. Mol Cancer Res. 19:1412. PubMed
  37. Opzoomer JW, et al. 2021. Sci Adv. 7:eabg9518. PubMed
  38. Paterson N, et al. 2022. Elife. 11:. PubMed
  39. Glass A, et al. 2013. J Immunol. 190:4830. PubMed
  40. Müller P, et al. 2015. Sci Transl Med. 7: 315ra188. PubMed
  41. Doty DT, et al. 2020. Int J Mol Sci. 21:00. PubMed
  42. Sokol CL et al. 2018. Immunity. 49(3):449-463 . PubMed
  43. Kobayashi S, et al. 2019. J Immunol. 203:1447. PubMed
  44. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
  45. Eggold JT, et al. 2022. Mol Cancer Ther. 21:371. PubMed
  46. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  47. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  48. Fennell LM, et al. 2020. EMBO J. 39:e103303. PubMed
  49. Chi A, et al. 2022. Front Endocrinol (Lausanne). 13:871548. PubMed
  50. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  51. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  52. Zenker S, et al. 2014. J Immunol. 192:2830. PubMed
  53. Li J, et al. 2020. Elife. 9:00. PubMed
  54. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  55. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  56. Enders M, et al. 2020. J Immunol. 204:87. PubMed
  57. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  58. Cao DY, et al. 2020. J Biol Chem. 295:1369. PubMed
  59. Textor A, et al. 2014. Cancer Res. 74:6769. PubMed
  60. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  61. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  62. He J, et al. 2019. J Clin Invest. 130. PubMed
  63. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  64. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  65. Sun M, et al. 2021. J Immunother Cancer. 9:. PubMed
  66. Troutman TD, et al. 2021. STAR Protocols. 2(1):100363. PubMed
  67. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  68. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  69. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  70. Guan X, et al. 2022. Nat Commun. 13:2834. PubMed
  71. Babagana M, et al. 2021. Aging (Albany NY). 13:19207. PubMed
  72. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  73. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  74. Chuang CH, et al. 2020. Cancer Research. 81(3):567-579. PubMed
  75. Lim J et al. 2019. Elife. 8 pii: e44452. PubMed
  76. McDonald LT, et al. 2018. Am J Physiol Heart Circ Physiol. 315:H92. PubMed
  77. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  78. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  79. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  80. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  81. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  82. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  83. Ledo JH, et al. 2020. PLoS One. e0237773:15. PubMed
  84. Barbet G, et al. 2018. Immunity. 48:584. PubMed
  85. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  86. Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed
  87. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  88. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  89. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  90. Heinen A, et al. 2019. Mol Ther. 27:46:00. PubMed
  91. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  92. Liao X, et al. 2022. JCI Insight. 7:. PubMed
  93. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  94. Crichton M, et al. 2016. Sci Rep. 6:27217. PubMed
  95. Fan HH, et al. 2021. Methods Mol Biol. 2276:203. PubMed
  96. Zhang Y, et al. 2021. JCI Insight. 6:e150735. PubMed
  97. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  98. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  99. Silva HM, et al. 2019. J Exp Med. 216:786. PubMed
  100. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  101. S?wen P et al. 2018. eLife. 7 pii: e41258. PubMed
  102. Ying L, et al. 2021. Front Cell Dev Biol. 9:672032. PubMed
  103. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  104. Schuster EM, et al. 2022. Nat Metab. 4:856. PubMed
  105. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  106. Shan Z, et al. 2021. eLife. 10:00. PubMed
  107. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  108. Ledo JH, et al. 2020. Mol Psychiatry. . PubMed
  109. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
  110. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  111. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  112. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  113. Yao W, et al. 2017. EBioMedicine. 10.1016/j.ebiom.2017.07.014. PubMed
RRID
AB_10901171 (BioLegend Cat. No. 123131) AB_2563102 (BioLegend Cat. No. 123137) AB_11203717 (BioLegend Cat. No. 123132)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kuffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线